Unity Biotechnology, Inc.
UBX
$0.977
-$0.0067-0.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -32.02% | -33.79% | 54.38% | 1.01% | -20.93% |
| Gross Profit | 32.02% | 33.79% | -54.38% | -1.01% | 20.28% |
| SG&A Expenses | -12.01% | -17.61% | -20.29% | -19.92% | -8.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.82% | -25.99% | -34.89% | -35.58% | -26.34% |
| Operating Income | 21.82% | 25.99% | 34.89% | 35.58% | 25.98% |
| Income Before Tax | 31.87% | 34.79% | 36.05% | 8.94% | -30.92% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 31.87% | 34.79% | 36.05% | 8.94% | -30.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.87% | 34.79% | 36.05% | 8.94% | -30.92% |
| EBIT | 21.82% | 25.99% | 34.89% | 35.58% | 25.98% |
| EBITDA | 21.74% | 25.97% | 34.92% | 35.50% | 25.30% |
| EPS Basic | 39.66% | 43.41% | 44.14% | 28.15% | 23.51% |
| Normalized Basic EPS | 35.54% | 40.01% | 31.92% | 41.65% | 33.64% |
| EPS Diluted | 39.66% | 43.41% | 44.14% | 28.15% | 23.51% |
| Normalized Diluted EPS | 35.54% | 40.01% | 31.92% | 41.65% | 33.64% |
| Average Basic Shares Outstanding | 9.49% | 13.92% | 15.16% | 20.76% | 35.43% |
| Average Diluted Shares Outstanding | 9.49% | 13.92% | 15.16% | 20.76% | 35.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |